Clinical Trial Update: Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and radiation dosimetry study evaluating the Technetium-99m EC-DG radiopharmaceutical with SPECT/CT in patients with non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Technetium-99m EC-DG (Technetium-99m EC-DG)

Snippet

Sponsor: Cell>Point LLC | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED